Canada authorizes Pfizer vaccine for children aged 5-11

Canada has authorised the use of the Pfizer coronavirus vaccine for children between the ages of 5 and 11.

Report informs, citing foreign media, that trials of the vaccine children showed similar safety and efficacy results to those recorded in trials among adults 16 to 25, according to Pfizer.

Health Canada had said it would only approve the vaccine for children if its analysis demonstrated benefits outweighed any possible risks.

It is the first Covid-19 vaccine approved for this age group in Canada.